Anti-PD1 antibody: a new approach to treatment of lymphomas

被引：32
|
作者：
Bachy, Emmanuel [1 ,2 ,3 ]
Coiffier, Bertrand [1 ,2 ,3 ]
机构：
[1] Hosp Civils Lyon, Dept Hematol, Lyon, France
[2] Univ Lyon 1, Dept Hematol, F-69365 Lyon, France
[3] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France
来源：
LANCET ONCOLOGY | 2014年 / 15卷 / 01期
关键词：
FOLLICULAR LYMPHOMA; T-CELLS; PD-1;
D O I：
10.1016/S1470-2045(13)70587-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [1] Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
    Fujita, Kohei
    Terashima, Tsuyoshi
    Mio, Tadashi
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (12) : 2238 - 2240
  • [2] Review of the Combination Strategies Used in Anti-PD1/PD-L1 Monoclonal Antibody Treatment
    Cheng, Jiaxing
    2020 INTERNATIONAL CONFERENCE ON ENERGY, ENVIRONMENT AND BIOENGINEERING (ICEEB 2020), 2020, 185
  • [3] Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma
    Simeone, Ester
    Grimaldi, Antonio M.
    Ascierto, Paolo A.
    MELANOMA MANAGEMENT, 2015, 2 (01) : 41 - 50
  • [4] Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibody
    Mamesaya, Nobuaki
    Kenmotsu, Hirotsugu
    Katsumata, Mineo
    Nakajima, Takashi
    Endo, Masahiro
    Takahashi, Toshiaki
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (01) : 105 - 107
  • [5] Anti-PD1 role in treatment of cutaneous melanoma
    Mateus, Christine
    Libenciuc, Cristina
    Robert, Caroline
    BULLETIN DU CANCER, 2016, 103 (06) : S4 - S11
  • [6] Osimertinib-induced interstitial lung disease after treatment with anti-PD1 antibody
    Nobuaki Mamesaya
    Hirotsugu Kenmotsu
    Mineo Katsumata
    Takashi Nakajima
    Masahiro Endo
    Toshiaki Takahashi
    Investigational New Drugs, 2017, 35 : 105 - 107
  • [7] Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma
    Tumeh, Paul Camille
    Rosenblum, Michael
    Handley, Nathan
    Tsai, Katy
    Rodriguez, Robert S. Rodriguez
    Khurana, Niharika
    Harview, Christina
    Spasic, Marko
    Sanchez, Phillip J.
    Chang, Jeremy
    Shintaku, I. Peter
    Taylor, Emma
    Chmielowski, Bartosz
    Grogan, Tristan
    Elashoff, David A.
    Pierce, Robert H.
    Daud, Adil
    CANCER RESEARCH, 2015, 75
  • [8] Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab
    Cousin, S.
    Toulmonde, M.
    Kind, M.
    Cazeau, A. -L.
    Bechade, D.
    Coindre, J. -M.
    Italiano, A.
    ANNALS OF ONCOLOGY, 2016, 27 (06) : 1178 - 1179
  • [9] Penpulimab, an anti-PD1 IgG1 antibody in the treatment of advanced or metastatic upper gastrointestinal cancers
    Yulong Zheng
    Anna Rachelle Austria Mislang
    Jermaine Coward
    Rasha Cosman
    Adam Cooper
    Craig Underhill
    Jianqing Zhu
    Jianping Xiong
    Ou Jiang
    Hong Wang
    Yanru Xie
    Yuefen Zhou
    Xiaoping Jin
    Baiyong Li
    Zhongmin Maxwell Wang
    Kon Yew Kwek
    Dennis Xia
    Yu Xia
    Nong Xu
    Cancer Immunology, Immunotherapy, 2022, 71 : 2371 - 2379
  • [10] Overcoming resistance to anti-PD1 and anti-PD-L1 treatment in gastrointestinal malignancies
    Puccini, Alberto
    Battaglin, Francesca
    Iaia, Maria Laura
    Lenz, Heinz-Josef
    Salem, Mohamed E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
12345